Dimeric organization of blood coagulation factor VIII bound to lipid nanotubes

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Dalm, Daniela ^a   Galaz Montoya, Jesus G ^b   Miller, Jaimy L ^a   Grushin, Kirill ^a   Villalobos, Alex ^a   Koyfman, Alexey Y ^a   Schmid, Michael F ^b   Stoilova McPhie, Svetla ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; LIPID; NANOTUBE; PROTEIN BINDING;

ANIMAL; CHEMISTRY; CRYOELECTRON MICROSCOPY; HUMAN; METABOLISM; MOLECULAR MODEL; PROCEDURES; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; TOMOGRAPHY;

ANIMALS; CRYOELECTRON MICROSCOPY; FACTOR VIII; HUMANS; LIPIDS; MODELS, MOLECULAR; NANOTUBES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; TOMOGRAPHY;

EID: 84935897774     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11212     Document Type: Article

References (75)

1. Fay, P. J. Factor VIII structure and function. International journal of hematology 83, 103-108, doi:10.1532/IJH97.05113 (2006).
2. Pipe, S. W. Hemophilia: new protein therapeutics. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2010, 203-209, doi:10.1182/asheducation-2010.1.203 (2010).
3. Furie, B. & Furie, B. C. Mechanisms of thrombus formation. The New England journal of medicine 359, 938-949, doi:10.1056/NEJMra0801082 (2008).
4. Duffy, E. J., Parker, E. T., Mutucumarana, V. P., Johnson, A. E. & Lollar, P. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles. The Journal of biological chemistry 267, 17006-17011 (1992).
5. Gilbert, G. E. & Arena, A. A. Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine. The Journal of biological chemistry 271, 11120-11125 (1996).
6. Toole, J. J. et al. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 312, 342-347 (1984).
7. Vehar, G. A. et al. Structure of human factor VIII. Nature 312, 337-342 (1984).
8. Lenting, P. J., van Mourik, J. A. & Mertens, K. The life cycle of coagulation factor VIII in view of its structure and function. Blood 92, 3983-3996 (1998).
9. Pemberton, S. et al. A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin. Blood 89, 2413-2421 (1997).
10. Kane, W. H. & Davie, E. W. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71, 539-555 (1988).
11. Hellman, N. E. et al. Mechanisms of copper incorporation into human ceruloplasmin. The Journal of biological chemistry 277, 46632-46638, doi:10.1074/jbc.M206246200 (2002).
12. Pratt, K. P. et al. Structure of the C2 domain of human factor VIII at 1.5 A resolution. Nature 402, 439-442, doi:10.1038/46601 (1999).
13. Stoilova-McPhie, S., Villoutreix, B. O., Mertens, K., Kemball-Cook, G. & Holzenburg, A. 3-Dimensional structure of membranebound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography. Blood 99, 1215-1223 (2002).
14. Derrick, T. S., Kashi, R. S., Durrani, M., Jhingan, A. & Middaugh, C. R. Effect of metal cations on the conformation and inactivation of recombinant human factor VIII. Journal of pharmaceutical sciences 93, 2549-2557, doi:10.1002/jps.20167 (2004).
15. Fay, P. J. Activation of factor VIII and mechanisms of cofactor action. Blood reviews 18, 1-15 (2004).
16. Pittman, D. D. & Kaufman, R. J. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). Proceedings of the National Academy of Sciences of the United States of America 85, 2429-2433 (1988).
17. Fay, P. J. & Smudzin, T. M. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa. The Journal of biological chemistry 267, 13246-13250 (1992).
18. Wakabayashi, H. & Fay, P. J. Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa. The Journal of biological chemistry 283, 11645-11651, doi:10.1074/jbc.M710252200 (2008).
19. Shen, B. W. et al. The tertiary structure and domain organization of coagulation factor VIII. Blood 111, 1240-1247, doi:10.1182/blood-2007-08-109918 (2008).
20. Lollar, P. & Parker, C. G. Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 28, 666-674 (1989).
21. Fay, P. J., Haidaris, P. J. & Smudzin, T. M. Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. The Journal of biological chemistry 266, 8957-8962 (1991).
22. Ngo, J. C., Huang, M., Roth, D. A., Furie, B. C. & Furie, B. Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex. Structure 16, 597-606, doi:10.1016/j.str.2008.03.001 (2008).
23. Lollar, P. & Parker, C. G. pH-dependent denaturation of thrombin-activated porcine factor VIII. The Journal of biological chemistry 265, 1688-1692 (1990).
24. Pipe, S. W., Eickhorst, A. N., McKinley, S. H., Saenko, E. L. & Kaufman, R. J. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo. Blood 93, 176-183 (1999).
25. Kemball-Cook, G., Edwards, S. J., Sewerin, K., Andersson, L. O. & Barrowcliffe, T. W. Factor VIII procoagulant protein interacts with phospholipid vesicles via its 80 kDa light chain. Thrombosis and haemostasis 60, 442-446 (1988).
26. Hsu, T. C., Pratt, K. P. & Thompson, A. R. The factor VIII C1 domain contributes to platelet binding. Blood 111, 200-208, doi:10.1182/blood-2007-01-068957 (2008).
27. Franchini, M. & Lippi, G. Recombinant factor VIII concentrates. Seminars in thrombosis and hemostasis 36, 493-497, doi:10.1055/s-0030-1255443 (2010).
28. Grushin, K. et al. Lack of recombinant factor VIII B-domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIII. Haemophilia 20, 723-731, doi:10.1111/hae.12421 (2014).
29. Barrow, R. T. & Lollar, P. Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIII. Journal of thrombosis and haemostasis: JTH 4, 2223-2229, doi:10.1111/j.1538-7836.2006.02135.x (2006).
30. Doering, C. B., Healey, J. F., Parker, E. T., Barrow, R. T. & Lollar, P. High level expression of recombinant porcine coagulation factor VIII. The Journal of biological chemistry 277, 38345-38349, doi:10.1074/jbc.M206959200 (2002).
31. Lollar, P., Parker, E. T. & Fay, P. J. Coagulant properties of hybrid human/porcine factor VIII molecules. The Journal of biological chemistry 267, 23652-23657 (1992).
32. Svensson, L. A., Thim, L., Olsen, O. H. & Nicolaisen, E. M. Evaluation of the metal binding sites in a recombinant coagulation factor VIII identifies two sites with unique metal binding properties. Biological chemistry 394, 761-765, doi:10.1515/hsz-2012-0298 (2013).
33. Liu, Z. et al. Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding. The Journal of biological chemistry 285, 8824-8829, doi:10.1074/jbc. M109.080168 (2010).
34. Meems, H., Meijer, A. B., Cullinan, D. B., Mertens, K. & Gilbert, G. E. Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity. Blood 114, 3938-3946, doi:10.1182/blood-2009-01-197707 (2009).
35. Lu, J., Pipe, S. W., Miao, H., Jacquemin, M. & Gilbert, G. E. A membrane-interactive surface on the factor VIII C1 domain cooperates with the C2 domain for cofactor function. Blood 117, 3181-3189, doi:10.1182/blood-2010-08-301663 (2011).
36. Novakovic, V. A. et al. Membrane-binding properties of the Factor VIII C2 domain. The Biochemical journal 435, 187-196, doi:10.1042/BJ20101797 (2011).
37. Stoilova-McPhie, S., Lynch, G. C., Ludtke, S. & Pettitt, B. M. Domain organization of membrane-bound factor VIII. Biopolymers 99, 448-459, doi:10.1002/bip.22199 (2013).
38. Lippi, G., Montagnana, M. & Franchini, M. Ex-vivo red blood cells generation: a step ahead in transfusion medicine? European journal of internal medicine 22, 16-19, doi:10.1016/j.ejim.2010.08.001 (2011).
39. Stoilova-McPhie, S., Parmenter, C. D., Segers, K., Villoutreix, B. O. & Nicolaes, G. A. Defining the structure of membrane-bound human blood coagulation factor Va. Journal of thrombosis and haemostasis: JTH 6, 76-82, doi:10.1111/j.1538-7836.2007.02810.x (2008).
40. Ahmad, S. S. & Walsh, P. N. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface. Biochemistry 41, 11269-11276 (2002).
41. Fay, P. J. & Jenkins, P. V. Mutating factor VIII: lessons from structure to function. Blood reviews 19, 15-27, doi:10.1016/j. blre.2004.02.003 (2005).
42. Jenkins, P. V., Freas, J., Schmidt, K. M., Zhou, Q. & Fay, P. J. Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex. Blood 100, 501-508, doi:10.1182/blood-2001-12-0361 (2002).
43. Fay, P. J., Beattie, T., Huggins, C. F. & Regan, L. M. Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site. The Journal of biological chemistry 269, 20522-20527 (1994).
44. Bajaj, S. P. et al. Factor IXa:factor VIIIa interaction. helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa. The Journal of biological chemistry 276, 16302-16309, doi:10.1074/jbc. M011680200 (2001).
45. Griffiths, A. E., Wintermute, J., Newell-Caito, J. L. & Fay, P. J. Residues flanking scissile bonds in Factor VIII modulate rates of cleavage and proteolytic activation catalyzed by Factor Xa. Biochemistry 52, 8060-8068, doi:10.1021/bi4010123 (2013).
46. Bloem, E., Meems, H., van den Biggelaar, M., Mertens, K. & Meijer, A. B. A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX. The Journal of biological chemistry 288, 26105-26111, doi:10.1074/jbc.M113.500884 (2013).
47. Lenting, P. J., van de Loo, J. W., Donath, M. J., van Mourik, J. A. & Mertens, K. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX. The Journal of biological chemistry 271, 1935-1940 (1996).
48. Mathur, A. & Bajaj, S. P. Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa. Importance of helix 330 (helix 162 in chymotrypsin) of protease domain of factor IXa in its interaction with factor VIIIa. The Journal of biological chemistry 274, 18477-18486 (1999).
49. Blostein, M. D., Furie, B. C., Rajotte, I. & Furie, B. The Gla domain of factor IXa binds to factor VIIIa in the tenase complex. The Journal of biological chemistry 278, 31297-31302, doi:10.1074/jbc.M302840200 (2003).
50. Soeda, T. et al. The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex. The Journal of biological chemistry 284, 3379-3388, doi:10.1074/jbc.M804955200 (2009).
51. Brandstetter, H., Bauer, M., Huber, R., Lollar, P. & Bode, W. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proceedings of the National Academy of Sciences of the United States of America 92, 9796-9800 (1995).
52. Autin, L. et al. Molecular models of the procoagulant factor VIIIa-factor IXa complex. Journal of thrombosis and haemostasis: JTH 3, 2044-2056, doi:10.1111/j.1538-7836.2005.01527.x (2005).
53. Parmenter, C. D. & Stoilova-McPhie, S. Binding of recombinant human coagulation factor VIII to lipid nanotubes. FEBS letters 582, 1657-1660, doi:10.1016/j.febslet.2008.04.018 (2008).
54. Parmenter, C. D., Cane, M. C., Zhang, R. & Stoilova-McPhie, S. Cryo-electron microscopy of coagulation Factor VIII bound to lipid nanotubes. Biochemical and biophysical research communications 366, 288-293, doi:10.1016/j.bbrc.2007.11.072 (2008).
55. Miller, J., Dalm, D., Koyfman, A. Y., Grushin, K. & Stoilova-McPhie, S. Helical organization of blood coagulation factor VIII on lipid nanotubes. J, doi:10.3791/51254 (2014).
56. Stoilova-McPhie, S., Grushin, K., Dalm, D. & Miller, J. Lipid nanotechnologies for structural studies of membrane-associated proteins. Proteins 82, 2902-2909, doi:10.1002/prot.24631 (2014).
57. Henderson, R. et al. Outcome of the first electron microscopy validation task force meeting. Structure 20, 205-214, doi:10.1016/j. str.2011.12.014 (2012).
58. Galaz-Montoya, J.G., Flanagan, J., Schmid, M.F., Ludtke, S.J. Single particle tomography in EMAN2. Journal of Structural Biology 2015 May 5 pii: S1047-8477(15)00101-X. doi: 10.1016/j.jsb.2015.04.016. [Epub ahead of print]
59. Shahmoradian, S. H. et al. TRiC's tricks inhibit huntingtin aggregation. eLife 2, e00710, doi:10.7554/eLife.00710 (2013).
60. Mutucumarana, V. P., Duffy, E. J., Lollar, P. & Johnson, A. E. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study. The Journal of biological chemistry 267, 17012-17021 (1992).
61. Pettersen, E. F. et al. UCSF Chimera - a visualization system for exploratory research and analysis. Journal of computational chemistry 25, 1605-1612, doi:10.1002/jcc.20084 (2004).
62. Goddard, T. D., Huang, C. C. & Ferrin, T. E. Visualizing density maps with UCSF Chimera. Journal of structural biology 157, 281-287, doi:10.1016/j.jsb.2006.06.010 (2007).
63. Pantazatos, D., Gessner, C. R., Woods, V. L., Jr. & Gilbert, G. E. Changes in the Factor VIII C2 domain upon membrane binding determined by hydrogen-deuterium exchange MS. The Biochemical journal 461, 443-451, doi:10.1042/BJ20140121 (2014).
64. Chaves, R. C., Dahmane, S., Odorico, M., Nicolaes, G. A. & Pellequer, J. L. Factor Va alternative conformation reconstruction using atomic force microscopy. Thrombosis and haemostasis 112, 1167-1173, doi:10.1160/TH14-06-0481 (2014).
65. Mack, E. T., Perez-Castillejos, R., Suo, Z. & Whitesides, G. M. Exact analysis of ligand-induced dimerization of monomeric receptors. Analytical chemistry 80, 5550-5555, doi:10.1021/ac800578w (2008).
66. Marianayagam, N. J., Sunde, M. & Matthews, J. M. The power of two: protein dimerization in biology. Trends in biochemical sciences 29, 618-625, doi:10.1016/j.tibs.2004.09.006 (2004).
67. Hvarregaard, J., Andersen, M. H., Berglund, L., Rasmussen, J. T. & Petersen, T. E. Characterization of glycoprotein PAS-6/7 from membranes of bovine milk fat globules. European journal of biochemistry/FEBS 240, 628-636 (1996).
68. Egelman, E. H. The iterative helical real space reconstruction method: surmounting the problems posed by real polymers. Journal of structural biology 157, 83-94, doi:10.1016/j.jsb.2006.05.015 (2007).
69. Egelman, E. H. Reconstruction of helical filaments and tubes. Methods in enzymology 482, 167-183, doi:10.1016/S0076-6879(10)82006-3 (2010).
70. Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. Journal of structural biology 152, 36-51, doi:10.1016/j.jsb.2005.07.007 (2005).
71. Kremer, J. R., Mastronarde, D. N. & McIntosh, J. R. Computer visualization of three-dimensional image data using IMOD. Journal of structural biology 116, 71-76, doi:10.1006/jsbi.1996.0013 (1996).
72. Schmid, M. F. & Booth, C. R. Methods for aligning and for averaging 3D volumes with missing data. Journal of structural biology 161, 243-248, doi:10.1016/j.jsb.2007.09.018 (2008).
73. Pintilie, G. D., Zhang, J., Goddard, T. D., Chiu, W. & Gossard, D. C. Quantitative analysis of cryo-EM density map segmentation by watershed and scale-space filtering, and fitting of structures by alignment to regions. Journal of structural biology 170, 427-438, doi:10.1016/j.jsb.2010.03.007 (2010).
74. Pintilie, G. & Chiu, W. Comparison of Segger and other methods for segmentation and rigid-body docking of molecular components in cryo-EM density maps. Biopolymers 97, 742-760, doi:10.1002/bip.22074 (2012).
75. Goddard, T. D. & Ferrin, T. E. Visualization software for molecular assemblies. Current opinion in structural biology 17, 587-595, doi:10.1016/j.sbi.2007.06.008 (2007).